SCHEMBL7995243

SCHEMBL7995243

O=C(NCC1C2CCCCC2C2CCCCC21)Nc1ccccc1Cl

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
TAS1R3 Q7RTX0 3/20 0.52
TAS1R1 Q7RTX1 3/20 0.52
CASR P41180 1/20 0.51
CYP2C19 P33261 1/20 0.49
HPGD P15428 2/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
CYP1A2 P05177 1/20 0.46
EPHX1 P07099 1/20 0.45
EPHX2 P34913 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8598568 0.76 NPC1 (0.52) NPC1RAB9ACASRCYP2C19HPGD
SCHEMBL8004908 0.75 TAS1R3 (0.63) NPC1RAB9ATAS1R3TAS1R1CASR
SCHEMBL2751208 0.74 RAB9A (0.97) NPC1RAB9ATAS1R3TAS1R1TP53
SCHEMBL8007467 0.74 MEN1 (0.62) NPC1RAB9ATAS1R3TAS1R1CASR
SCHEMBL11336178 0.73 RAB9A (1.00) NPC1RAB9ATAS1R3TAS1R1CYP2C19
SCHEMBL8004565 0.72 CASR (0.50) NPC1RAB9ATAS1R3TAS1R1CASR
SCHEMBL4351271 0.72 EPHX1 (0.60) NPC1RAB9ATAS1R3TAS1R1TP53
SCHEMBL10458447 0.72 KDM4E (0.72) NPC1RAB9ACYP2C19HPGDMAPK1
SCHEMBL13480553 0.71 TAS1R3 (0.60) NPC1RAB9ATAS1R3TAS1R1CASR
SCHEMBL27714794 0.71 MAPK1 (0.61) NPC1RAB9ATAS1R3TAS1R1CASR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6060484-A Anti-viral method ELI LILLY AND COMPANY (US) 2000-05-09 US disclosed
EP-0806205-A2 Urea, thiourea and guanidine compounds and their use as anti-viral agents ELI LILLY AND COMPANY (US) 1997-11-12 EP disclosed